Bruno Julianne — SEC insider filings

SEC reporting owner CIK 2019645. 11 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-05-24 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CRISPR Therapeutics AG (CRSP)Chief Operating Officer7—5 legs · 6,801 sh · $336,10014
Damora Therapeutics, Inc. (DMRA)Director2——3
InMed Pharmaceuticals Inc. (MTRI)Director2——1

Insider filings — Bruno Julianne

FiledFormIssuerReported transactionsSource
2026-11-123InMed Pharmaceuticals Inc. (MTRI)Holdings only — no transactions reportedEDGAR
2026-11-124InMed Pharmaceuticals Inc. (MTRI)Grant/award (A): 37,000 (derivative) @ $0EDGAR
2026-03-254Damora Therapeutics, Inc. (DMRA)Grant/award (A): 37,313 (derivative) @ $0EDGAR
2026-02-124Galecto, Inc. (GLTO)Option exercise (M): 129,000 @ $0 · Option exercise (M): 129 (derivative) @ $0EDGAR
2025-03-244CRISPR Therapeutics AG (CRSP)Option exercise (M): 3,750 · Sale (S): 1,714 @ $41.23 · Option exercise (M): 3,750 (derivative)EDGAR
2025-03-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 36,666 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0EDGAR
2025-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,399 · Sale (S): 1,198 @ $42.42 · Option exercise (M): 435 · Sale (S): 190 @ $43.32 · Option exercise (M): 2,399 (derivative) · Option exercise (M): 435 (derivative)EDGAR
2025-02-194CRISPR Therapeutics AG (CRSP)Option exercise (M): 650 · Sale (S): 333 @ $52.80 · Option exercise (M): 650 (derivative)EDGAR
2024-10-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 18,333 (derivative) @ $0EDGAR
2024-06-244CRISPR Therapeutics AG (CRSP)Option exercise (M): 7,000 · Sale (S): 3,366 @ $56.09 · Option exercise (M): 7,000 (derivative)EDGAR
2024-05-244CRISPR Therapeutics AG (CRSP)Grant/award (A): 20,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2019645 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs